Navigation Links
Quality standards for biological, chemical drugs and public health are focus of India meeting
Date:1/24/2011

Rockville, Md., January 24, 2011 In collaboration with key stakeholders, the United States Pharmacopeial Convention (USP) and the Indian Pharmacopoeia Commission (IPC) will host the 2011 IPC-USP 10th Science & Standards Symposium on February 17 and 18, 2011 in Hyderabad, India. The event reflects India's rise as a supplier of medicines worldwide, bringing USP closer to its Indian counterpart in the interest of promoting global public health.

The symposium aims to facilitate a science-based dialogue among key stakeholderssuch as standard-setting bodies, government officials, policy makers, pharmaceutical manufacturers and academiato address relevant topics affecting the region and thereby promote access to quality medicines. Attendees will have the opportunity to network with thought leaders, obtain industry benchmark information and contribute early in the standard-setting process for both IPC and USP.

Along with USP and IPC, additional co-sponsors include Bulk Drug Manufacturers Association (BDMA), Indian Drug Manufacturers' Association (IDMA), Organization of Pharmaceutical Producers of India (OPPI) and Pharmacy Council of India (PCI).

"For a decade, these annual IPC-USP meetings have brought together key experts and innovators throughout the Indian pharmaceutical landscape as well from the United States and other countries," said Roger L. Williams, M.D., chief executive officer, USP. "As India's role in the global pharmaceutical industry continues its rapid growth, collaborations within India and with partners around the world are essential to helping to ensure public health." Previous events were known as Annual Scientific Meetings.

Sessions on chemical drugs will be part of symposium highlights, covering topics as varied as quality by design, standards-setting, impurities, chemical reference materials/uncertainty measurement and strategies for combating counterfeit drugs. Biological drugs will also be emphasized in sessions that explore regulatory approaches; standards for biologics and biotechnology drugs; critical quality attributes; reference materials; standards for vaccines and monoclonal antibodies and strategies for combating adulteration of drugs.

"The IPC values its longstanding relationship with USP," stated G.N. Singh, Ph.D., secretary-cum-scientific director, IPC. "We are confident this year's forum will result in a better understanding among participants of the status and issues facing the IPC and USP in standards-setting."


'/>"/>

Contact: Theresa Laranang-Mutlu
trl@usp.org
301-816-8167
US Pharmacopeia
Source:Eurekalert

Related biology news :

1. CU-Boulder study suggests air quality regulations miss key pollutants
2. Biological sand filters, a practical approach to combat poverty and inequality
3. New standard for popular stevia-based sweetener to assure products quality
4. New research shows high-quality protein in eggs contributes to power, strength and energy
5. Healthy food availability could depend on where you live -- so does the quality of your diet
6. Houseplants increase quality of life for retirement community residents
7. Enhanced quality of LIFE through Nordic food
8. Prefilled WFI Syringe Provides a High-Quality Solution for Drug Reconstitution
9. Quality and purity of popular stevia sweetener strengthened by new reference standards
10. Dietary supplements manufacturers gain new tool to help ensure quality products
11. Improved air quality during Beijing Olympics could inform pollution-curbing policies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
Breaking Biology Technology: